<生产厂家价格>

6-溴己酸

6-溴己酸用途

用于血小板活化因子拮抗物的合成。也用于其它有机合成。

6-溴己酸名称

[ CAS 号 ]:
4224-70-8

[ 中文名 ]:
6-溴己酸

[ 英文名 ]:
6-Bromohexanoic acid

[中文别名 ]:

[英文别名 ]:

6-bromo hexanoic acid
EINECS 224-176-5
Hexanoic acid,6-bromo
6-Bromocaproic acid
bromopentylcarboxylic acid
6-Bromo-n-caproic acid
Hexanoic acid, 6-bromo-
1-bromo-5-carboxypentane
6-Bromohexanoic acid
MFCD00004422

6-溴己酸物理化学性质

[ 密度 ]:
1.4±0.1 g/cm3

[ 沸点 ]:
279.2±0.0 °C at 760 mmHg

[ 熔点 ]:
32-34 °C(lit.)

[ 分子式 ]:
C₆H₁₁BrO₂

[ 分子量 ]:
195.054

[ 闪点 ]:
67.8±0.0 °C

[ 精确质量 ]:
193.994232

[ PSA ]:
37.30000

[ LogP ]:
1.70

[ 外观性状 ]:
白色至略米色晶体或结晶粉末

[ 蒸汽压 ]:
0.0±1.2 mmHg at 25°C

[ 折射率 ]:
1.490

[ 储存条件 ]:
2-8°C

[ 水溶解性 ]:
methanol: 0.1 g/mL, clear, colorless

6-溴己酸MSDS

6-溴己酸安全信息

[ 符号 ]:

GHS05

[ 信号词 ]:
Danger

[ 危害声明 ]:
H314

[ 警示性声明 ]:
P280-P305 + P351 + P338-P310

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
C:Corrosive

[ 风险声明 (欧洲) ]:
R34

[ 安全声明 (欧洲) ]:
S26-S36/37/39-S45-S28A

[ 危险品运输编码 ]:
UN 3261 8/PG 2

[ WGK德国 ]:
3

[ 包装等级 ]:
III

[ 危险类别 ]:
8

[ 海关编码 ]:
29159080

6-溴己酸合成路线

6-溴己酸上下游产品

6-溴己酸上游产品

6-溴己酸下游产品

6-溴己酸海关

[ 海关编码 ]: 2915900090

[ 中文概述 ]:
2915900090. 其他饱和无环一元羧酸及其酸酐（酰卤、过氧）化物、过氧酸及其卤化、硝化、磺化、亚硝化衍生物. 增值税率:17.0%. 退税率:9.0%. 监管条件:AB(入境货物通关单,出境货物通关单). 最惠国关税:5.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ 监管条件 ]: A.入境货物通关单 B.出境货物通关单

[ 检验检疫 ]: R.进口食品卫生监督检验 S.出口食品卫生监督检验 M.进口商品检验 N.出口商品检验

[ Summary ]:
2915900090 other saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:5.5% General tariff:30.0%

6-溴己酸文献

A Combination of Targeted Sunitinib Liposomes and Targeted Vinorelbine Liposomes for Treating Invasive Breast Cancer.

J. Biomed. Nanotechnol. 11 , 1568-82, (2015)

Regular chemotherapy cannot eradicate invasive breast cancer cells and the residual cancer cells will form vasculogenic mimicry (VM) channels under hypoxic conditions to provide nutrients for cancer m...

Mitochondria apoptosis pathway synergistically activated by hierarchical targeted nanoparticles co-delivering siRNA and lonidamine.

Biomaterials 61 , 178-89, (2015)

The mitochondria-mediated apoptosis pathway is an effective option for cancer therapy due to the presence of cell-suicide weapons in mitochondria. However, anti-apoptotic proteins that are over-expres...

Shared Ligands Between Organic Anion Transporters (OAT1 and OAT6) and Odorant Receptors.

Drug Metab. Dispos. 43 , 1855-63, (2015)

The multispecific organic anion drug transporters OAT6 (SLC22A20) and OAT1 (SLC22A6) are expressed in nasal epithelial cells and both can bind odorants. Sequence analysis of OAT6 revealed an evolution...

更多文献